(Q28259404)

9

object named as

Alexandra Trkola

0 references

Paul R Clapham

10

object named as

Paul Clapham

0 references

author name string

Tonie Cilliers

1

0 references

Samantha Willey

2

0 references

W Mathew Sullivan

3

0 references

Trudy Patience

4

0 references

Pavel Pugach

5

0 references

Mia Coetzer

6

0 references

Maria Papathanasopoulos

7

0 references

John P Moore

Identification and characterization of HIV-2 strains obtained from asymptomatic patients that do not use CCR5 or CXCR4 coreceptors.

8

0 references

language of work or name

English

0 references

publication date

15 August 2005

0 references

published in

Virology

0 references

volume

339

0 references

page(s)

136-44

0 references

issue

1

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

CD4+CD25high regulatory cells in human peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

HIV-1 Subtype A, D, G, AG and unclassified sequences identified in South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Sensitivity of HIV type 1 subtype C isolates to the entry inhibitor T-20.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Expression cloning of new receptors used by simian and human immunodeficiency viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

HIV-1 membrane fusion: targets of opportunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

T cell dynamics in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

CCR8 on human thymocytes functions as a human immunodeficiency virus type 1 coreceptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

The entry of entry inhibitors: a fusion of science and medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Full-length genome analysis of HIV-1 subtype C utilizing CXCR4 and intersubtype recombinants isolated in South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Coreceptor usage of BOB/GPR15 and Bonzo/STRL33 by primary isolates of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Anti-human immunodeficiency virus interactions of SCH-C (SCH 351125), a CCR5 antagonist, with other antiretroviral agents in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Identification of a subset of human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus strains able to exploit an alternative coreceptor on untransformed human brain and lymphoid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

HIV type 1 molecular clones able to use the Bonzo/STRL-33 coreceptor for virus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

7 January 2021

Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

7 January 2021

Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

7 January 2021

Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.027

7 January 2021